Company / Shareholders' Equity
RxSight, Inc. Shareholders' Equity History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$275.7M
FY2025
5-year range
$89.9M / $281.2M
FY2021-FY2025
Trend
-2.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $160M to $276M over the past 2 years.
Based on SEC 10-K filings.
$276M in FY2025 with a 3-year CAGR of +45.3%.
Improved from $160M to $276M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +45.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +45.3%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 2.0% year-over-year.
- Peak shareholders' equity was recorded in FY2024.
- Lowest shareholders' equity in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.59 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $275.7M | -2.0% |
| FY2024 | $281.2M | +75.4% |
| FY2023 | $160.4M | +78.4% |
| FY2022 | $89.9M | -35.0% |
| FY2021 | $138.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026